Literature DB >> 11162976

Efficacy and tolerability outcomes after punctal occlusion with silicone plugs in dry eye syndrome.

M Balaram1, D A Schaumberg, M R Dana.   

Abstract

PURPOSE: Silicone punctal plugs are widely used to conserve moisture in tear-deficient eyes. We studied the efficacy and tolerability of punctal plugs in symptom reduction and improvement of ocular surface disease parameters in dry eye syndrome.
METHODS: We reviewed the records of 50 consecutive patients with dry eye syndrome who were symptomatic despite maximally tolerable lubricant therapy and had bilateral lower punctal plug insertion. After plug insertion, all patients (41 women and nine men) had 6 months or more of follow-up. The subjects ranged in age from 22 to 57 years (mean, 30 years). We recorded subjective and objective improvement of ocular surface disease, frequency of lubricant use, need for upper punctal occlusion, and occurrence of complications after plug insertion. We determined plug retention rates using Kaplan-Meier analyses and assessed associated factors using Cox proportional hazards models.
RESULTS: Six months after initial plug placement, 43 of 50 patients (86%) were symptom free, 28 of them (56%) with plugs alone, and 38 patients (76%) had stopped using lubricants on a daily basis. Spontaneous loss of plugs was common, especially in the initial 3 months of follow-up. Considering all plugs, the estimated probability of plug retention was 63% after 6 months of follow-up. Puncta refitted after initial plug loss were twice as likely to lose the replacement plug (P =.02). Upper punctal plugs showed a 4.3-fold higher risk of loss compared with plugs inserted in lower puncta (P <.0001).
CONCLUSIONS: There is both a reduced dependency on artificial lubricants and relief of symptoms of dry eye after punctal plugs. However, spontaneous plug loss occurs in a substantial minority of patients. Patient education and close follow-up, particularly in the first 3 months, is recommended to detect plug loss and ensure adequate control of the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11162976     DOI: 10.1016/s0002-9394(00)00620-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  18 in total

Review 1.  [Dry eye. An update on epidemiology, diagnosis, therapy and new concepts].

Authors:  F Schirra; K W Ruprecht
Journal:  Ophthalmologe       Date:  2004-01       Impact factor: 1.059

Review 2.  [Current treatment for dry eye syndrome].

Authors:  C Cursiefen; C Jacobi; T Dietrich; F E Kruse
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

Review 3.  [Current therapeutic options in Sjögren's syndrome].

Authors:  A Hansen; T Dörner
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 4.  Review of Approaches for Increasing Ophthalmic Bioavailability for Eye Drop Formulations.

Authors:  Olivia L Lanier; Miranda G Manfre; Claire Bailey; Zhen Liu; Zachary Sparks; Sandesh Kulkarni; Anuj Chauhan
Journal:  AAPS PharmSciTech       Date:  2021-03-14       Impact factor: 3.246

5.  Corneal sensitivity, ocular surface health and tear film stability after punctal plug therapy of aqueous deficient dry eye.

Authors:  Azza Mohamed Ahmed Said; Mona Elsayed Farag; Tarek Mohamed Abdulla; Othman Ali Othman Ziko; Wesam Mohamed Osman
Journal:  Int J Ophthalmol       Date:  2016-11-18       Impact factor: 1.779

Review 6.  Punctal occlusion for dry eye syndrome.

Authors:  Ann-Margret Ervin; Robert Wojciechowski; Oliver Schein
Journal:  Cochrane Database Syst Rev       Date:  2010-09-08

Review 7.  Recent advances in ophthalmic drug delivery.

Authors:  Uday B Kompella; Rajendra S Kadam; Vincent H L Lee
Journal:  Ther Deliv       Date:  2010-09

8.  Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.

Authors:  Rohan Bir Singh; Ann Yung; Giulia Coco; Shruti Sinha; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2020-07-30       Impact factor: 5.033

9.  Surgical punctal occlusion: a prospective study.

Authors:  D Liu; Y Sadhan
Journal:  Br J Ophthalmol       Date:  2002-09       Impact factor: 4.638

10.  Oral pilocarpine for the treatment of ocular symptoms in patients with Sjögren's syndrome: a randomised 12 week controlled study.

Authors:  N Tsifetaki; G Kitsos; C A Paschides; Y Alamanos; V Eftaxias; P V Voulgari; K Psilas; A A Drosos
Journal:  Ann Rheum Dis       Date:  2003-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.